Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord-derived MSCs for Rotator Cuff Repair
NCT06817616Recruiting
- Sponsor
- Korea University Anam Hospital
- Start
- Jan 2025
- Primary completion
- Apr 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of allogeneic umbilical cord-derived mesenchymal stem cells in rotator cuff tear, sponsored by Korea University Anam Hospital. Primary endpoint: Visual Analog Scale pain in motion at 12 months. Started Jan 2025; status: recruiting.
02
Drugs
allogeneic umbilical cord-derived mesenchymal stem cells
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT06817616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06817616.